Author:
Basak Grzegorz W.,Jaksic Ozren,Koristek Zdenek,Mikala Gabor,Mayer Jiri,Masszi Tamas,Labar Boris,Wiktor-Jedrzejczak Wieslaw,
Reference17 articles.
1. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells;Pusic;Curr Opin Hematol,2010
2. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: Compassionate use data;Calandra;Bone Marrow Transplant,2008
3. Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program;Hubel;Bone Marrow Transplant
4. Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: The Austrian experience on a named patient program;Worel;Transfusion
5. Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience;Basak;Ann Hematol,2011
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献